Comparison of clinical effect of shilajatwadi yog and kaishore guggul in vatarakta (gout)

A comparative clinical study to evaluate effect of shilajatwadi yog and kaishore guggul for management of vatarakta (gout) - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/12/099422

Enrollment

120

Registered

2025-12-18

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing to participate and provide written consent. Patients have serum uric acid levels of more than 6mg/dl in females & more than 7mg/dl in males with or without any associated features like joint pain and inflammation.

Exclusion criteria

Exclusion criteria: 1. Patients suffering from other forms of Arthritis like Rheumatoid arthritis, Osteoarthritis, Ankylosing spondylitis, Infective arthritis, etc and reporting with positive RA factor. 2. Pregnant and lactating mother. 3. Subject showing the uric acid level above 10mg/dl. 4. Patients with evidence of malignancy & on chemotherapy drugs. 5. Patients of CRF, ARF ,Cardiomyopathy and chronic ailments with complications.

Design outcomes

Primary

Measure	Time frame
Serum Uric AcidTimepoint: Baseline, 14 days and 28 days	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Rakesh Sharma

Shri Krishna AYUSH University

drashishhmehta@gmail.com8950375285

Outcome results